Perfluorohexyloctane
Perfluorohexyloctane is a medication used for the treatment of dry eye disease. It is a semifluorinated alkane.
Perfluorohexyloctane has been available in multiple markets since 2015 under the brand names Evotears and Novatears, and was additionally approved for medical use in the United States in May 2023 under the brand name Miebo. The US Food and [Drug Administration] considers it to be a first-in-class medication.
Medical uses
Perfluorohexyloctane is indicated for the treatment of the signs and symptoms of dry eye disease.Availability
Perfluorohexyloctane is sold as an over-the-counter medication under the brand names Evotears and Novatears in multiple countries, costing around NZ$34.00, A$30, and €30 for a one-month supply.In the US, perfluorohexyloctane is sold under the brand name Miebo; a prescription is required. Perfluorohexyloctane was approved by Health Canada in September 2024.